Champions Oncology Inc (CSBR) support and resistance · P/E 16, rev $56.9M
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
This page maps Champions Oncology Inc (CSBR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CSBR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CSBR quote page for the session range and the stock page for the full model.
Not investment advice.